The entire team, from management to the front store staff, has been incredibly helpful and welcoming
Impacts among markets differ due to factors including differences in the current obesity rates and future expected obesity trends, medication uptake (cost and eligibility), and the cause-of-death mix
However, the company also appreciates that not everyone will be satisfied with the results
Transparency is the whole game in a market with no retail pharmacy oversight
If they do not, the weight returns
April 1, 2026: More Lawsuits Join Vision Loss MDL for GLP-1 Drugs, Like Ozempic As of April 1, 2026, there are 73 pending lawsuits in the centralized litigation for people alleging NAION from GLP-1 drugs, including Ozempic